- Wound care company Advanced Medical Solutions reaffirmed its dividend even as the Covid-19 impact was denting revenue by as much as 5% a month.

As a result of the pandemic hit to operations, the company 'has been experiencing reductions to its revenues at the upper end of the 3% to 5% of annual sales per month estimate announced by the board in April,' the company said.

Advanced Medical Solutions said the impact of the pandemic would continue, albeit at a lower level, in the second half of the year.

Despite expectations for a gradual return to more normalised levels of hospital activity for both its surgical and woundcare businesses, the company said it expected the effects of Covid-19 'will continue to have an impact in the second half of 2020, albeit at a lower level, as volumes will take time to recover to pre-COVID-19 levels.'

The company reconfirmed its intention to recommend the payment of the proposed final dividend for 2019.

At 8:04am: [LON:AMS] Advanced Medical Solutions Group PLC share price was -1p at 251.5p.

Story provided by